Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamed Alborzinia

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|November 19, 2010
Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor propertiesRiccardo Rubbiani, Igor Kitanovic, Hamed Alborzinia, et al.
Molecules (Basel, Switzerland)|September 23, 2014
The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cellsPieter Spincemaille, Hamed Alborzinia, Jeroen Dekervel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 28, 2014
A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complexIgor Kitanovic, Suzan Can, Hamed Alborzinia, et al.
Cell Death & Disease|January 21, 2018
Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosisHaristi Gaitantzi, Christoph Meyer, Pia Rakoczy, et al.
Journal of Medicinal Chemistry|April 22, 2015
Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 InducersXinlai Cheng, Eleni Dimou, Hamed Alborzinia, et al.
Journal of Medicinal Chemistry|July 7, 2015
Ethyl 2-((4-Chlorophenyl)amino)thiazole-4-carboxylate and Derivatives Are Potent Inducers of Oct3/4Xinlai Cheng, Hiroki Yoshida, Dena Raoofi, et al.
Molecular Oncology|February 19, 2016
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACsXinlai Cheng, Jee Young Kim, Shahrouz Ghafoory, et al.
Redox Biology|March 23, 2023
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugsJana Samarin, Piotr Fabrowski, Roman Kurilov, et al.
Nature Communications|April 11, 2026
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapyJana Samarin, Hana Nůsková, Piotr Fabrowski, et al.
EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|November 19, 2010
Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor propertiesRiccardo Rubbiani, Igor Kitanovic, Hamed Alborzinia, et al.
Molecules (Basel, Switzerland)|September 23, 2014
The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cellsPieter Spincemaille, Hamed Alborzinia, Jeroen Dekervel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 28, 2014
A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complexIgor Kitanovic, Suzan Can, Hamed Alborzinia, et al.
Cell Death & Disease|January 21, 2018
Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosisHaristi Gaitantzi, Christoph Meyer, Pia Rakoczy, et al.
Journal of Medicinal Chemistry|April 22, 2015
Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 InducersXinlai Cheng, Eleni Dimou, Hamed Alborzinia, et al.
Journal of Medicinal Chemistry|July 7, 2015
Ethyl 2-((4-Chlorophenyl)amino)thiazole-4-carboxylate and Derivatives Are Potent Inducers of Oct3/4Xinlai Cheng, Hiroki Yoshida, Dena Raoofi, et al.
Molecular Oncology|February 19, 2016
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACsXinlai Cheng, Jee Young Kim, Shahrouz Ghafoory, et al.
Redox Biology|March 23, 2023
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugsJana Samarin, Piotr Fabrowski, Roman Kurilov, et al.
Nature Communications|April 11, 2026
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapyJana Samarin, Hana Nůsková, Piotr Fabrowski, et al.
EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Pageof 5